Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver
NCT00366795
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
241
Enrollment
INDUSTRY
Sponsor class
Stopped
Study was terminated due to safety reason.
Conditions
Ascites
Liver Cirrhosis
Interventions
DRUG:
Satavaptan
DRUG:
placebo
Sponsor
Sanofi